BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 27, 2004

View Archived Issues

CHMP adopts extension of indication for Schering-Plough HCV products

Read More

Merck researchers describe new anti-HIV vaccines

Read More

New Eg5 kinesin inhibitors developed by AstraZeneca researchers

Read More

Novel JNK inhibitors and their use reported by Eisai

Read More

Agents combining antimitotic, antiangiogenic and PDE4 activity claimed by Celgene

Read More

Novel MCH receptor antagonists prepared and tested at Schering-Plough

Read More

Roche claims new 5-HT6 receptor ligands for cognitive disorders, psychosis, etc.

Read More

Urea-based glycogen phosphorylase a inhibitors newly developed at Aventis

Read More

New 5-HT2C receptor modulators under study at GSK

Read More

Series B financing at Othera to accelerate pipeline development

Read More

Japanese approval sought for Advate

Read More

Final approval and first-to-file status for Alpharma's gabapentin

Read More

Phase II study for Levulan Kerastick in acne

Read More

Spiriva approved for Japanese import

Read More

Dacogen MAA accepted for review

Read More

Japanese approval for Trisenox

Read More

Urocortin 2 evaluated in new phase I study

Read More

Evoclin approved for acne vulgaris

Read More

Velac NDA accepted for filing

Read More

Ivax signs U.S. agreement for citicoline

Read More

Emerging companies showcased at the 12th Annual BioPartnering Europe conference: Austrianova

Read More

Emerging companies showcased at the 12th Annual BioPartnering Europe conference: Ionix

Read More

Nociceptin opioid receptor antagonist may be useful in the management of addictive disorders

Read More

Improved nucleoside triphosphate analogue promising against HCV infection

Read More

Reversal of multidrug resistance in tumor cells by FG-020318

Read More

TAS-108 evaluated in advanced breast cancer

Read More

Fampridine-SR active in multiple sclerosis

Read More

Studies reveal teriflunomide efficacy in treating multiple sclerosis

Read More

Superoxide-driven nitration of endogenous MnSOD critical in NMDA-mediated hyperalgesia

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 4, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 4, 2025.
  • Green molecules

    UK Biobank delivers largest metabolomics dataset of 500K profiles

    BioWorld Science
    It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
  • 3D rendering of prion structure

    Epigenetic technology could eliminate misfolded prion proteins

    BioWorld Science
    The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
  • Mesothelin is biomarker, potential target in arthritic bone damage

    BioWorld Science
    In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing